FDA: Baxter recalls four lots of IV solutions

Editor's Note

The Food and Drug Administration (FDA) on January 27 announced that Baxter (Deerfield, Illinois) is recalling four lots of IV solutions because of the potential for leaking containers and particulate matter.

The recall affects the following:

• 0.9% Sodium Chloride Injection, USP, 100 mL in Mini-Bag Plus Container (lot numbers P337857 and P328997)
• Metronidazole Injection, USP, 500 mg/100 mL (lot number P339135)
• Clinimix E 5/15 (5% AA w/Electrolytes in 15% Dextrose w/Calcium (lot number P333930).

The recall is a result of two complaints of leaking containers and one customer complaint each for three lots that had particulate matter.

0.9% Sodium Chloride Injection, USP, 100mL in Mini-Bag Plus Container Metronidazole Injection, USP 500mg/100mL Clinimix E 5/15 (5% AA w/Electrolytes in 15% Dextrose w/Calcium) [Posted 01/27/2016] AUDIENCE: Risk Manager, Nursing, Infectious Disease ISSUE: Baxter is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user level due to the potential for leaking containers and particulate matter.